SBTX DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Silverback Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
SAN DIEGO, Nov. 11, 2021 (GLOBE NEWSWIRE) — Robbins Geller Rudman & Dowd LLP announces that purchasers of : (a) Silverback Therapeutics Inc. (NASDAQ: SBTX) common stock pursuant and/or traceable to the offering documents issued in connection with Silverback…
